Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Non Operating Income for 8 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 30.64% year-over-year to $6.7 million, compared with a TTM value of $37.2 million through Sep 2025, up 38.65%, and an annual FY2024 reading of $36.1 million, up 235.93% over the prior year.
  • Non Operating Income was $6.7 million for Q3 2025 at Bicycle Therapeutics, down from $7.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $14.7 million in Q4 2024 and bottomed at -$799000.0 in Q3 2021.
  • Average Non Operating Income over 5 years is $3.6 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Non Operating Income crashed 1209.72% in 2021, then skyrocketed 77322.22% in 2024.
  • Year by year, Non Operating Income stood at -$761000.0 in 2021, then skyrocketed by 338.24% to $1.8 million in 2022, then skyrocketed by 200.94% to $5.5 million in 2023, then soared by 169.92% to $14.7 million in 2024, then tumbled by 54.8% to $6.7 million in 2025.
  • Business Quant data shows Non Operating Income for BCYC at $6.7 million in Q3 2025, $7.4 million in Q2 2025, and $8.4 million in Q1 2025.